• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

萨拉曼卡大学SARS-CoV-2抗体血清阳性率及与血清阳性相关的因素:DIANCUSAL研究

Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study.

作者信息

Muro Antonio, Belhassen-García Moncef, Muñoz Bellido Juan Luís, Lorenzo Juanes Helena, Vicente Belén, Pendones Josué, Adserias José, Sánchez Hernández Gonzalo, Rodríguez Rosa Miguel, Vicente Villardón José Luis, Burguillo Javier, López Andaluz Javier, Martín Oterino Jose Angel, García Criado Francisco Javier, Barbero Fausto, Morales Ana Isabel, Galindo Villardón Purificación, González Sarmiento Rogelio

机构信息

Infectious and Tropical Diseases Group (e-INTRO), Institute of Biomedical Research of Salamanca-Research Center for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.

Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, University Hospital of Salamanca, 37007 Salamanca, Spain.

出版信息

J Clin Med. 2021 Jul 21;10(15):3214. doi: 10.3390/jcm10153214.

DOI:10.3390/jcm10153214
PMID:34361998
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8348112/
Abstract

BACKGROUND

Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillance of the COVID-19 pandemic. The University of Salamanca (USAL) in Spain designed a project called "DIANCUSAL" (Diagnosis of New Coronavirus, COVID-19, in University of Salamanca) to measure antibodies against SARS-CoV-2 among its ~34,000 students and academic staff, as the influence of the university community in the spread of the SARS-CoV-2 pandemic in the city of Salamanca and neighboring towns hosting USAL campuses could be substantial.

OBJECTIVE

The aim of this study was to estimate the prevalence of SARS-CoV-2 antibodies among USAL students, professors and staff and to evaluate the demographic, academic, clinical and lifestyle and behavioral factors related to seropositivity.

METHODOLOGY

The DIANCUSAL study is an ongoing university population-based cross-sectional study, with the work described herein conducted from July-October 2020. All USAL students, professors and staff were invited to complete an anonymized questionnaire. Seroprevalence of anti-SARS-CoV-2 antibodies was detected and quantified by using chemiluminescent assays for IgG and IgM.

PRINCIPAL FINDINGS

A total of 8197 (24.71%) participants were included. The mean age was 31.4 (14.5 SD) years, and 66.0% of the participants were female. The seroprevalence was 8.25% overall and was highest for students from the education campus (12.5%) and professors from the biomedical campus (12.6%), with significant differences among faculties ( = 0.006). Based on the questionnaire, loss of smell and fever were the symptoms most strongly associated with seropositivity, and 22.6% of seropositive participants were asymptomatic. Social distancing was the most effective hygiene measure ( = 0.0007). There were significant differences in seroprevalence between participants with and without household exposure to SARS-CoV-2 ( = 0.0000), but not between students who lived in private homes and those who lived in dormitories. IgG antibodies decreased over time in the participants with confirmed self-reported COVID-19 diagnoses.

CONCLUSIONS

The analysis revealed an overall 8.25% seroprevalence at the end of October 2020, with a higher seroprevalence in students than in staff. Thus, there is no need for tailored measures for the USAL community as the official average seroprevalence in the area was similar (7.8% at 22 June and 12.4 at 15 November of 2020). Instead, USAL members should comply with public health measures.

摘要

背景

对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体进行系统筛查是监测新冠疫情的一项关键工具。西班牙萨拉曼卡大学(USAL)设计了一个名为“DIANCUSAL”(萨拉曼卡大学新型冠状病毒2019冠状病毒病诊断)的项目,以检测其约34000名学生和学术人员体内的SARS-CoV-2抗体,因为大学社区对SARS-CoV-2疫情在萨拉曼卡市及设有USAL校区的周边城镇传播的影响可能很大。

目的

本研究旨在估计USAL学生、教授和工作人员中SARS-CoV-2抗体的流行率,并评估与血清阳性相关的人口统计学、学术、临床、生活方式和行为因素。

方法

DIANCUSAL研究是一项正在进行的基于大学人群的横断面研究,本文所述工作于2020年7月至10月开展。邀请所有USAL学生、教授和工作人员填写一份匿名问卷。采用化学发光法检测和定量抗SARS-CoV-2抗体的血清阳性率,检测IgG和IgM。

主要发现

共纳入8197名(24.71%)参与者。平均年龄为31.4(标准差14.5)岁,66.0%的参与者为女性。总体血清阳性率为8.25%,教育校区的学生(12.5%)和生物医学校区的教授(12.6%)血清阳性率最高,各学院之间存在显著差异(P = 0.006)。根据问卷,嗅觉丧失和发热是与血清阳性最密切相关的症状,22.6%的血清阳性参与者无症状。保持社交距离是最有效的卫生措施(P = 0.0007)。有SARS-CoV-2家庭接触史和无家庭接触史的参与者之间血清阳性率存在显著差异(P = 0.0000),但居住在私人住宅的学生和居住在宿舍的学生之间无差异。在确诊为自我报告的新冠病例的参与者中,IgG抗体随时间下降。

结论

分析显示,截至2020年10月底,总体血清阳性率为8.25%,学生的血清阳性率高于工作人员。因此,由于该地区官方平均血清阳性率相似(2020年6月22日为7.8%,11月15日为12.4%),无需为USAL社区采取针对性措施。相反,USAL成员应遵守公共卫生措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab8/8348112/a6bc3d9bc40e/jcm-10-03214-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab8/8348112/55814a822b0b/jcm-10-03214-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab8/8348112/b8cdde715ac3/jcm-10-03214-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab8/8348112/9d46f264c074/jcm-10-03214-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab8/8348112/a6bc3d9bc40e/jcm-10-03214-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab8/8348112/55814a822b0b/jcm-10-03214-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab8/8348112/b8cdde715ac3/jcm-10-03214-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab8/8348112/9d46f264c074/jcm-10-03214-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab8/8348112/a6bc3d9bc40e/jcm-10-03214-g004.jpg

相似文献

1
Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study.萨拉曼卡大学SARS-CoV-2抗体血清阳性率及与血清阳性相关的因素:DIANCUSAL研究
J Clin Med. 2021 Jul 21;10(15):3214. doi: 10.3390/jcm10153214.
2
Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.美国中西部一个公立学校系统工作人员中抗新冠病毒2型免疫球蛋白G抗体的血清流行率
medRxiv. 2020 Oct 27:2020.10.23.20218651. doi: 10.1101/2020.10.23.20218651.
3
Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021.对 2020 年 9 月至 2021 年 7 月间罗马(意大利)一群大学生的血清阳性率进行回顾性分析。
Epidemiol Prev. 2022 Sep-Dec;46(5-6):367-375. doi: 10.19191/EP22.5-6.A461.088.
4
Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.2021 年 10 月至 2022 年 11 月巴西南马托格罗索州坎波格兰德市学校社区中针对 SARS-CoV-2 的抗体血清阳性率。
Front Immunol. 2024 Mar 26;15:1354786. doi: 10.3389/fimmu.2024.1354786. eCollection 2024.
5
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.在印度克什米尔第二次大流行期间,SARS-CoV-2 特异性抗刺突 IgM、IgG 和抗核衣壳 IgG 抗体的血清阳性率:一项全人群横断面调查。
Front Public Health. 2022 Oct 6;10:967447. doi: 10.3389/fpubh.2022.967447. eCollection 2022.
6
Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study.2020年7月至8月在马萨诸塞州进行的血清学调查以估计成人中SARS-CoV-2感染的累积发病率(血清大规模研究):一项基于邮件的横断面研究。
medRxiv. 2021 May 6:2021.03.05.21249174. doi: 10.1101/2021.03.05.21249174.
7
COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.COVID-19 在第一波和第二波疫情(2020 年)期间综合癌症中心工作人员中的流行情况:西班牙加泰罗尼亚的一项血清流行率研究。
BMJ Open. 2022 Apr 21;12(4):e056637. doi: 10.1136/bmjopen-2021-056637.
8
A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France).法国科西嘉岛大学人群在第二波疫情期间 SARS-CoV-2 抗体血清阳性相关暴露因素的横断面研究。
Int J Environ Res Public Health. 2022 Feb 10;19(4):1953. doi: 10.3390/ijerph19041953.
9
Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.希腊儿童及其父母的抗 SARS-CoV-2 抗体血清阳性率。
Eur J Pediatr. 2023 Jan;182(1):439-449. doi: 10.1007/s00431-022-04681-8. Epub 2022 Nov 16.
10
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia.索马里贝纳迪尔地区抗新冠病毒抗体的血清阳性率
Vaccines (Basel). 2022 Jan 30;10(2):220. doi: 10.3390/vaccines10020220.

引用本文的文献

1
[SARS-CoV-2 Exposure and Seroprevalence of SARS-CoV-2 Antibodies among Medical Students in the First Phase of the Pandemic 2020-2021].[2020 - 2021年大流行第一阶段医学生中SARS-CoV-2暴露情况及SARS-CoV-2抗体血清流行率]
Gesundheitswesen. 2024 Apr;86(4):311-314. doi: 10.1055/a-2183-7279. Epub 2024 Jan 5.
2
Predictors of SARS-CoV-2 Infection in University Students: A Case-Control Study.大学生 SARS-CoV-2 感染的预测因素:一项病例对照研究。
Int J Environ Res Public Health. 2022 Nov 3;19(21):14376. doi: 10.3390/ijerph192114376.

本文引用的文献

1
Seroprevalence Study and Cross-Sectional Survey on COVID-19 for a Plan to Reopen the University of Alicante (Spain).《西班牙阿利坎特大学复课计划的 COVID-19 血清流行率研究和横断面调查》。
Int J Environ Res Public Health. 2021 Feb 16;18(4):1908. doi: 10.3390/ijerph18041908.
2
Seroprevalence of SARS-CoV-2 antibodies in low-income university students.低收入大学生中新冠病毒2型抗体的血清流行率
EXCLI J. 2021 Feb 9;20:276-280. doi: 10.17179/excli2021-3459. eCollection 2021.
3
Inferring the effectiveness of government interventions against COVID-19.
推断政府干预 COVID-19 的效果。
Science. 2021 Feb 19;371(6531). doi: 10.1126/science.abd9338. Epub 2020 Dec 15.
4
Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis.家庭传播的 SARS-CoV-2:系统评价和荟萃分析。
JAMA Netw Open. 2020 Dec 1;3(12):e2031756. doi: 10.1001/jamanetworkopen.2020.31756.
5
Smoking and COVID-19: What we know so far.吸烟与 COVID-19:目前我们已知的情况。
Respir Med. 2021 Jan;176:106237. doi: 10.1016/j.rmed.2020.106237. Epub 2020 Nov 19.
6
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.全球范围内 SARS-CoV-2 血清流行率:系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Mar;27(3):331-340. doi: 10.1016/j.cmi.2020.10.020. Epub 2020 Oct 24.
7
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands.在荷兰 COVID-19 疫情早期,献血者中 SARS-CoV-2 血清流行率较低。
Nat Commun. 2020 Nov 12;11(1):5744. doi: 10.1038/s41467-020-19481-7.
8
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.新型冠状病毒肺炎患者和健康志愿者发病后 6 个月内抗 SARS-CoV-2 抗体的血清阳性率。
Eur J Immunol. 2020 Dec;50(12):2025-2040. doi: 10.1002/eji.202048970. Epub 2020 Nov 10.
9
A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population.一项横断面研究调查大学生人群中严重急性呼吸综合征冠状病毒 2 抗体的血清阳性率。
J Adolesc Health. 2020 Dec;67(6):763-768. doi: 10.1016/j.jadohealth.2020.09.001. Epub 2020 Oct 15.
10
Coronavirus disease 2019 (COVID-19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease.新型冠状病毒病 2019(COVID-19)与肥胖。肥胖及其主要合并症对疾病演变的影响。
Eur Eat Disord Rev. 2020 Nov;28(6):799-815. doi: 10.1002/erv.2770. Epub 2020 Sep 25.